4//SEC Filing
Leneis Melissa 4
Accession 0000081362-24-000068
CIK 0000081362other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:11 PM ET
Size
10.1 KB
Accession
0000081362-24-000068
Insider Transaction Report
Form 4
Leneis Melissa
SVP, CHRO
Transactions
- Sale
Common Stock
2024-05-17$192.22/sh−1,618$311,010→ 2,609 total - Exercise/Conversion
Common Stock
2024-05-17$142.38/sh+1,618$230,371→ 4,227 total - Sale
Common Stock
2024-05-17$194.19/sh−400$77,678→ 2,609 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-05-17−1,618→ 1,411 totalExercise: $142.38Exp: 2029-03-16→ Common Stock (1,618 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.9907 to $192.35, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The options for this grant vest in three annual installments: 1,410 shares on March 16, 2023; 1,410 shares on March 16, 2024; and 1,411 shares on March 16, 2025.
Documents
Issuer
QUAKER CHEMICAL CORP
CIK 0000081362
Entity typeother
Related Parties
1- filerCIK 0001935345
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:11 PM ET
- Size
- 10.1 KB